NCBI PubMed Central
open access
Astragaloside IV suppresses triple-negative breast cancer cell migration and invasion by targeting BCAT1-mediated branched-chain amino acid metabolism.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Decreasing stearoyl‐ C o A desaturase‐1 expression inhibits β‐catenin signaling in breast cancer cells#218117
- Identification of cellular determinants of responseto systemic treatment in triple-negative breast carcinomas#1166380
- Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study#869312
- Replicate Data For: Cancer-associated BCL-2 mutants reveal mechanisms towards venetoclax resistance#399477
- Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)#1152627
Record · ID 455258
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive